Osaic Holdings’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-64
| Closed | -$4.76K | – | 7429 |
|
|
2024
Q1 | $4.76K | Sell |
64
-4
| -6% | -$297 | ﹤0.01% | 6004 |
|
|
2023
Q4 | $12.1K | Sell |
68
-100
| -60% | -$17.7K | ﹤0.01% | 5707 |
|
|
2023
Q3 | $118K | Buy |
168
+165
| +5,500% | +$116K | ﹤0.01% | 4378 |
|
|
2023
Q2 | $12.4K | Hold |
3
| – | – | ﹤0.01% | 5823 |
|
|
2023
Q1 | $7.2K | Sell |
3
-2
| -40% | -$4.8K | ﹤0.01% | 6115 |
|
|
2022
Q4 | $13K | Hold |
5
| – | – | ﹤0.01% | 5806 |
|
|
2022
Q3 | $20K | Hold |
5
| – | – | ﹤0.01% | 5581 |
|
|
2022
Q2 | $13K | Hold |
5
| – | – | ﹤0.01% | 5909 |
|
|
2022
Q1 | $16K | Sell |
5
-2
| -29% | -$6.4K | ﹤0.01% | 5827 |
|
|
2021
Q4 | $42K | Hold |
7
| – | – | ﹤0.01% | 5257 |
|
|
2021
Q3 | $62K | Buy |
7
+1
| +17% | +$8.86K | ﹤0.01% | 4942 |
|
|
2021
Q2 | $56K | Buy |
6
+4
| +200% | +$37.3K | ﹤0.01% | 4958 |
|
|
2021
Q1 | $35K | Sell |
2
-1
| -33% | -$17.5K | ﹤0.01% | 5113 |
|
|
2020
Q4 | $18K | Hold |
3
| – | – | ﹤0.01% | 5194 |
|
|
2020
Q3 | $11K | Buy |
3
+2
| +200% | +$7.33K | ﹤0.01% | 5213 |
|
|
2020
Q2 | $3K | Hold |
1
| – | – | ﹤0.01% | 5635 |
|
|
2020
Q1 | $1K | Buy |
+1
| New | +$1K | ﹤0.01% | 5848 |
|